1st Edition
Atypical Antipsychotics From Bench to Bedside
360 Pages
by
CRC Press
360 Pages
by
CRC Press
Also available as eBook on:
Showcasing the latest studies in the field, this reference unveils recent breakthroughs in the use of atypical antipsychotics for the treatment of a variety of patient populations-tracking developments in the management of patients with schizophrenia and affective psychotic disorders, as well as therapeutic regimens for children and adolescents.
Atypical Antipsychotic Drugs: Theories of Mechanism of Action Scott Filippino and John G. Csernansky; Probing the Receptorsome Unveils the Receptor Pharmacology of Atypical Antipsychotic Drugs Bryan L. Roth; Neurophysiological Effects of Atypical Antipsychotic Drugs Patricio O'Donnell; Behavioral Models of Atypical Antipsychotic Drug Action in Rodents Mark E. Bardgett; Metabolic Regulation and Atypical Antipsychotic Drugs Pierre Chue; The Nosology of Psychosis: Schizophrenia, Affective Psychotic Disorders, and Drug-Induced Psychotic Disorders John Lauriello; Acute Efficacy of Atypical Antipsychotic Drugs Steve Marder; Long-Term Efficacy of Atypical Antipsychotic Drugs Robert Conley; Assessing the Effects of Atypical Antipsychotics on the CNS Utilizing Neuroimaging Juan Bustillo; Use of Atypical Antipsychotic Drugs in Children and Adolescents Peter Buckley; Use of Atypical Antipsychotic Drugs for the Treatment of Affective Disorders Martha Sajatovic; New Approaches to Drug Development Donald C. Goff; Index
Biography
John C. Csernansky, Washington University School of Medicine, St Louis Missouri. John Lauriello, University of New Mexico, Albuquerque.
"provide[s] current useful and intelligent reviews."
-American Journal of Psychiatry